ENT Biotech Solutions
Grosse Pointe Farms, US · Founded 2011 · Michigan corporation
Find your way into ENT Biotech Solutions
Sign up to see every warm intro you have to ENT Biotech Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ENT Biotech Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JB
Jeffery BrinzaExecutive
AR
Andrea Roumell DicksonNamed on SEC filing
CB
C. Barthell DicksonNamed on SEC filing
Board
JB
Jack BallBoard director
GK
Gretchen KnoellBoard director
Reported raises · per SEC filings
Form D private placements$2M disclosed across 2 rounds · 2014–2015
▶$1.1MraisedApr 2016 · 17 investors · Other Health CareRule 506(b)
▶$1.1MraisedApr 2016 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jack BallDirector
- Andrea Roumell DicksonExecutive Officer, Director, Promoter
- C. Barthell DicksonDirector, Promoter
- Jeffery BrinzaExecutive Officer, Director
- Gretchen KnoellDirector
- Olivier LecerfExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.1M
- Minimum investment
- $11.7K
- First sale
- Mar 2015
- Incorporated
- Corporation, Michigan, 2011
- Federal exemptions
- 06b
▶$940KraisedJul 2014 · 14 investors · Other Health CareRule 506(b)
▶$940KraisedJul 2014 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gretchen KnoellDirector
- Jack BallDirector
- Olivier LecerfExecutive Officer
- Andrea Roumell DicksonExecutive Officer, Director, Promoter
- C. Barthell DicksonDirector, Promoter
- Jeffery BrinzaExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $940K
- Minimum investment
- $25K
- First sale
- Mar 2014
- Incorporated
- Corporation, Michigan, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ENT Biotech Solutions raised?
- ENT Biotech Solutions has disclosed $2M raised across 2 rounds.
- Where is ENT Biotech Solutions headquartered?
- ENT Biotech Solutions is headquartered in Grosse Pointe Farms, US.